erlotinib hydrochloride has been researched along with methylnitrosourea in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (methylnitrosourea) | Trials (methylnitrosourea) | Recent Studies (post-2010) (methylnitrosourea) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 3,242 | 10 | 346 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode, A; Gill, SC; Grubbs, CJ; Iwata, KK; Juliana, MM; Lubet, RA; Nicastro, HL; Steele, VE; Szabo, E; Tucker, C | 1 |
1 other study(ies) available for erlotinib hydrochloride and methylnitrosourea
Article | Year |
---|---|
Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.
Topics: Alkylating Agents; Animals; Blotting, Western; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Mammary Neoplasms, Animal; Methylnitrosourea; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Survival Rate; Tissue Distribution | 2013 |